BCL-2 family protein BOK is a positive regulator of uridine metabolism in mammals
Rahul Srivastava,Zhipeng Cao,Christina Nedeva,Samara Naim,Daniel Bachmann,Tatiana Rabachini,Lahiru Gangoda,Sanjay Shahi,Jason Glab,Joseph Menassa,Laura Osellame,Tao Nelson,Yuniel Fernandez-Marrero,Fiona Brown,Andrew Wei,Francine Ke,Lorraine O'Reilly,Marcel Doerflinger,Cody Allison,Andrew Kueh,Rob Ramsay,Brian J Smith,Suresh Mathivanan,Thomas Kaufmann,Hamsa Puthalakath,Lorraine O’Reilly,Brian J. Smith
DOI: https://doi.org/10.1073/pnas.1904523116
IF: 11.1
2019-07-16
Proceedings of the National Academy of Sciences
Abstract:Significance It is believed that the Bcl-2 family protein Bok has a redundant role similar to Bax and Bak in regulating apoptosis. We report that this protein interacts with the key enzyme involved in uridine biosynthesis, uridine monophosphate synthetase, and positively regulates uridine biosynthesis and chemoconversion of 5-fluorouracil (5-FU). Bok-deficient cell lines are resistant to 5-FU. Bok down-regulation is a key feature of cell lines and primary colorectal tumor tissues that are resistant to 5-FU. Our data also show that through its impact on nucleotide metabolism, Bok regulates p53 level and cellular proliferation. Our results have implications for developing Bok as a biomarker for 5-FU resistance and for the development of BOK mimetics for sensitizing 5-FU-resistant cancers.
multidisciplinary sciences